tetradecanoylphorbol acetate has been researched along with ursodeoxycholic acid in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Güldütuna, S; Leuschner, U; Sipos, P; Vallent, K | 1 |
Bouscarel, B; Dubner, H; Fromm, H; Gettys, TW | 1 |
Handa, H; Hiramoto, M; Hirano, F; Makino, I; Makino, Y; Okamoto, K; Tanada, H | 1 |
Inaba, K; Ishikawa, H; Kashima, K; Matsumoto, M; Mitsuyoshi, H; Nakajima, Y; Nakashima, T; Okanoue, T; Sakamoto, Y | 1 |
Gohda, E; Hiramatsu, K; Matsumoto, Y; Miyazaki, M; Tsubouchi, H; Yamamoto, I | 1 |
Kelleher, D; Long, A; Looby, E; Shah, SA; Volkov, Y | 1 |
1 trial(s) available for tetradecanoylphorbol acetate and ursodeoxycholic acid
Article | Year |
---|---|
[Comparative study of superoxide production of monocytes in primary biliary cirrhosis].
Topics: Anions; Cholagogues and Choleretics; Cholelithiasis; Female; Humans; Liver Cirrhosis, Biliary; Male; Monocytes; Superoxides; Tetradecanoylphorbol Acetate; Ursodeoxycholic Acid | 1995 |
5 other study(ies) available for tetradecanoylphorbol acetate and ursodeoxycholic acid
Article | Year |
---|---|
Ursodeoxycholic acid inhibits glucagon-induced cAMP formation in hamster hepatocytes: a role for PKC.
Topics: Angiotensin II; Animals; Bile Acids and Salts; Calcium; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Glucagon; Liver; Male; Mesocricetus; Protein Kinase C; Receptors, Glucagon; Tetradecanoylphorbol Acetate; Ursodeoxycholic Acid | 1995 |
Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids.
Topics: Activating Transcription Factor 1; Adenocarcinoma; Base Sequence; Bile Acids and Salts; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholic Acid; Cholic Acids; Colonic Neoplasms; Deoxycholic Acid; DNA Primers; DNA-Binding Proteins; DNA, Neoplasm; Enzyme Activation; Gene Expression Regulation; Genetic Vectors; Humans; Lithocholic Acid; Molecular Sequence Data; NF-kappa B; Podophyllin; Podophyllotoxin; Protein Kinase C; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Transcription Factors; Tumor Cells, Cultured; Ursodeoxycholic Acid | 1996 |
Ursodeoxycholic acid enhances glucocorticoid-induced tyrosine aminotransferase-gene expression in cultured rat hepatocytes.
Topics: Animals; Biomarkers; Calcimycin; Cells, Cultured; Dactinomycin; Dexamethasone; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Ionophores; Liver; Male; Protein Kinase Inhibitors; Rats; Rats, Wistar; Receptors, Glucocorticoid; RNA, Messenger; Sphingosine; Tetradecanoylphorbol Acetate; Tyrosine Transaminase; Up-Regulation; Ursodeoxycholic Acid | 1997 |
Inhibition of hepatocyte growth factor production in human fibroblasts by ursodeoxycholic acid.
Topics: Cell Line; Cholera Toxin; Dose-Response Relationship, Drug; Down-Regulation; Fibroblasts; Gene Expression; Hepatocyte Growth Factor; Humans; Mitogen-Activated Protein Kinases; Tetradecanoylphorbol Acetate; Ursodeoxycholic Acid | 2005 |
Ursodeoxycholic acid inhibits translocation of protein kinase C in human colonic cancer cell lines.
Topics: Anticarcinogenic Agents; Blotting, Western; Cell Line, Tumor; Cell Shape; Colonic Neoplasms; Deoxycholic Acid; Green Fluorescent Proteins; Humans; Protein Kinase C; Tetradecanoylphorbol Acetate; Transfection; Ursodeoxycholic Acid | 2005 |